Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

20.12%

Threshold

Crossed downwards

Timeline

Published

08.12.2012

Transaction

04.12.2012

Voting rights breakdown

Voting rights acquired0%

Voting rights sold20.12%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TACC600087

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4005 Basel

Einräumung von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, Allschwil08.12.2012TACC600087

Disclosure summary

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 08.12.2012, at 20.12% of voting rights. Notice category: Single shareholder.

Disclosed position

20.12%

Voting rights sold

Voting rights acquired0%

Voting rights sold20.12%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 08.12.2012.

Publication date08.12.2012

Transaction date04.12.2012

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica AG

Declared addressBasilea Pharmaceutica AG, 4005 Basel

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold20.12%

Below threshold0%

ExchangeXSWX

Notification IDTACC600087

Commercial register

CHE-101.175.068

Registered

Zefix record

Conditions

Einräumung von Mitarbeiteroptionen gemäss Optionsplan, welche zum Erwerb von Namenaktien der Basilea Pharmaceutica AG (Basiswert, Bezugsverhältnis 1:1) oder entsprechendem Cash Settlement berechtigen.

Source: SIX Exchange Regulation · Publication date: 08.12.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open